Theravance Biopharma CEO Rick Winningham's 2020 pay rises 11% to $6.6M
Theravance Biopharma reports 2020 executive compensation
By ExecPay News
Published: March 22, 2021
Theravance Biopharma reported fiscal year 2020 executive compensation information on March 22, 2021.
In 2020, five executives at Theravance Biopharma received on average a compensation package of $3.4M, a 21% increase compared to previous year.
Average pay of disclosed executives at Theravance Biopharma
Rick E Winningham, Chief Executive Officer, received $6.6M in total, which increased by 11% compared to 2019. 76% of Winningham's compensation, or $5M, was in stock awards. Winningham also received $580K in non-equity incentive plan, $1M in salary, as well as $6K in other compensation.
For fiscal year 2020, the median employee pay was $269,883 at Theravance Biopharma. Therefore, the ratio of Rick E Winningham's pay to the median employee pay was 24 to one.
Vijay Sabesan, Senior Vice President, Technical Operations, received a compensation package of $3.1M. 62% of the compensation package, or $1.9M, was in stock awards.
Brett Haumann, Chief Medical Officer, earned $2.7M in 2020, a 11% increase compared to previous year.
Bradford J. Shafer, General Counsel, received $2.7M in 2020, which increases by 11% compared to 2019.
Andrew A. Hindman, Chief Financial Officer, earned $2.1M in 2020, a 44% decrease compared to previous year.
Related executives
Rick Winningham
Theravance Biopharma
Chief Executive Officer
Andrew Hindman
Theravance Biopharma
Chief Financial Officer
Brett Haumann
Theravance Biopharma
Chief Medical Officer
Vijay Sabesan
Theravance Biopharma
Senior Vice President, Technical Operations
Bradford Shafer
Theravance Biopharma
General Counsel
You may also like
Source: SEC filing on March 22, 2021.